Table 1.
Year and quarter | AHT prescriptions (million) | Drug packages (million) | Drug packages per prescription |
---|---|---|---|
2017 Q1 | 23.6 | 28.9 | 1.22 |
2017 Q2 | 23.9 | 29.4 | 1.24 |
2017 Q3 | 23.6 | 29.0 | 1.23 |
2017 Q4 | 24.4 | 30.0 | 1.23 |
2018 Q1 | 23.9 | 29.4 | 1.23 |
2018 Q2 | 24.4 | 30.0 | 1.23 |
2018 Q3 | 23.9 | 29.2 | 1.22 |
2018 Q4 | 24.6 | 30.2 | 1.23 |
2019 Q1 | 24.0 | 29.4 | 1.22 |
2019 Q2 | 24.7 | 30.3 | 1.22 |
2019 Q3 | 24.5 | 30.1 | 1.23 |
2019 Q4 | 25.2 | 31.0 | 1.22 |
Total | 290.8 | 356.8 | 1.23 |
Average per quarter | 24.2 million | 29.7 million | 1.227 |
AHT antihypertensive drugs, Q quarter.